DRUG RECOVERY CENTRE — PHUKET, THAILAND
GHB Addiction
A clinical guide to GHB (gamma-hydroxybutyrate) addiction, its dangerous withdrawal syndrome, the narrow margin between recreational dose and overdose, and medically supervised treatment at Phuket Island Rehab.
Table of Contents
What Is GHB Addiction?
GHB addiction is a compulsive pattern of using gamma-hydroxybutyrate or its precursors (GBL and 1,4-butanediol) despite significant risks and negative consequences. GHB is a naturally occurring substance in the human brain that acts primarily on GABA-B receptors and its own specific GHB receptors, producing dose-dependent effects ranging from mild euphoria and social disinhibition at low doses to deep sedation and unconsciousness at higher doses.
Originally synthesised in 1960 as an anaesthetic, GHB gained popularity in nightlife and chemsex scenes throughout the 1990s and 2000s. Its reputation as a “party drug” belies its significant danger: GHB accounts for a disproportionate share of drug-related emergency department presentations and overdose deaths relative to its user base. In Australia, GHB is responsible for more overdose-related ambulance attendances per user than any other illicit substance.
How GHB Addiction Develops
GHB addiction typically follows a progression from recreational nightlife use to around-the-clock dosing that is uniquely rapid among recreational drugs.
Initial use: GHB produces euphoria, increased sociability, reduced inhibition, and enhanced tactile sensation at recreational doses (typically 1-2ml of liquid). The effects onset rapidly (15-30 minutes) and are short-lived (2-4 hours), encouraging redosing within a single session.
Escalation and tolerance: GABA-B receptor adaptation develops quickly with regular use, and the short duration of effects encourages increasingly frequent dosing. Users may progress from weekend-only use to every-other-day use to multiple daily doses within weeks. Some dependent users dose every 1-3 hours around the clock, including setting alarms to dose through the night.
Physical dependence: Unlike many club drugs, GHB produces profound physical dependence. The GABA-B receptor downregulation creates a state where cessation triggers severe withdrawal that can begin within 1-6 hours of the last dose. This rapid onset of withdrawal, combined with the short half-life, creates a uniquely compulsive use pattern driven by physical necessity as much as psychological desire.
Signs of GHB Addiction
| Category | Warning Signs |
|---|---|
| Dosing patterns | Carrying GHB at all times, dosing every few hours, setting overnight alarms to dose, panic when supply runs low |
| Overdose history | Episodes of losing consciousness (“going under”), breathing difficulties, ambulance call-outs, treating these as normal |
| Withdrawal symptoms | Anxiety, tremor, sweating, and insomnia within hours of missing a dose |
| Social changes | Social circle narrowing to other GHB users, chemsex involvement, relationship deterioration, work impairment |
| Combination use | Using GHB with alcohol, methamphetamine, or mephedrone (significantly increases overdose and death risk) |
GHB Withdrawal and Medical Detoxification
GHB withdrawal is the most clinically significant aspect of treating GHB addiction and distinguishes it from most other club drugs. The withdrawal syndrome results from GABA-B receptor downregulation and typically begins 1-6 hours after the last dose in dependent users.
Withdrawal severity is classified into three stages. Mild withdrawal includes anxiety, insomnia, tremor, and tachycardia. Moderate withdrawal adds confusion, hallucinations, significant autonomic instability, and nausea. Severe withdrawal involves delirium, seizures, rhabdomyolysis, and potentially fatal autonomic crisis. The severity depends primarily on dose, frequency, and duration of use.
Medical detoxification protocols for GHB withdrawal typically employ high-dose benzodiazepines (diazepam or lorazepam) as the primary pharmacological intervention, sometimes supplemented with baclofen (a GABA-B agonist that addresses the specific receptor system involved) and, in severe cases, barbiturates or propofol in an intensive care setting. The acute withdrawal phase typically lasts 5-15 days, with residual insomnia and anxiety persisting for weeks.
Treatment for GHB Addiction
Beyond the critical withdrawal management phase, effective GHB addiction treatment addresses the psychological and social factors that drive use.
Post-detox stabilisation: The period following acute withdrawal requires ongoing medical monitoring, sleep support (insomnia can persist for weeks), and mood stabilisation. Trazodone or mirtazapine are commonly used for persistent insomnia, and psychiatric evaluation for co-occurring conditions is essential.
Psychological treatment: CBT targets the specific triggers and cognitive patterns sustaining GHB use, which often include chemsex involvement, social anxiety, body image issues (GHB is popular in bodybuilding communities for its growth hormone effects), and trauma. Motivational interviewing helps resolve ambivalence about leaving social scenes where GHB use is normalised.
Harm reduction and relapse planning: Given the lethality of GHB overdose, relapse prevention planning must include specific safety strategies. At Phuket Island Rehab, we provide comprehensive aftercare planning that addresses the social and environmental factors unique to GHB addiction.
When Substance Use Becomes More Than Occasional
GHB use can escalate from occasional to dependent use with alarming speed. The transition is often marked by the first experience of withdrawal symptoms between doses, the shift from weekend-only to weekday use, needing GHB to sleep, and finding yourself unable to socialise or have intimate encounters without it.
“GHB dependence can develop faster than almost any other recreational drug. I have seen patients progress from first use to around-the-clock physical dependence in as little as three weeks of daily use. The speed of this progression catches people off guard, and by the time they recognise the problem, they cannot safely stop without medical help.” — Dr. Ponlawat Pitsuwan
Frequently Asked Questions
Can you die from GHB withdrawal?
Yes. GHB withdrawal can be fatal, primarily through seizures and severe autonomic instability. The mortality risk is comparable to alcohol or benzodiazepine withdrawal. This is why medically supervised detoxification is absolutely essential for anyone physically dependent on GHB. Never attempt to stop abruptly.
What is the difference between GHB and GBL?
GBL (gamma-butyrolactone) and 1,4-butanediol are precursor chemicals that are converted to GHB in the body after ingestion. GBL is more rapidly absorbed and produces faster onset of effects. The addiction profile and withdrawal risks are identical, as the active substance in all cases is GHB. GBL is often preferred by users because it is easier to obtain as an industrial solvent.
How long does GHB detox take?
Acute GHB withdrawal typically lasts 5-15 days, with the most severe symptoms occurring in the first 3-5 days. However, residual symptoms including insomnia, anxiety, and cognitive difficulties can persist for 2-6 weeks. Full neurological recovery may take several months. The detox process requires continuous medical supervision throughout the acute phase.
How does Phuket Island Rehab treat GHB addiction?
Our programme provides medically supervised GHB detoxification with 24-hour clinical monitoring, using evidence-based pharmacological protocols (benzodiazepines, baclofen where indicated) to manage withdrawal safely. Following stabilisation, patients enter an intensive therapeutic programme addressing the psychological and social dimensions of GHB addiction, with particular expertise in chemsex-related dependencies and nightlife drug patterns common across the Asia-Pacific region.
Ketamine Addiction · MDMA Addiction · LSD Addiction · Amphetamine Addiction · Alcohol Addiction · Fentanyl Addiction · Prescription Drug Addiction · Medical Detox
Clinical Reviewer: Dr. Ponlawat Pitsuwan, Physician | Publisher: Phuket Island Rehab | Last Updated: April 2026 | Clinical Entities: Gamma-Hydroxybutyrate (GHB), Gamma-Butyrolactone (GBL), 1,4-Butanediol, GABA-B Receptor, GHB Withdrawal Syndrome, Baclofen, Benzodiazepine Detoxification, Chemsex, Rhabdomyolysis, Autonomic Instability